Duh D, Blazic B. Single mutation in the matrix gene of seasonal influenza A viruses critically affects the performance of diagnostic molecular assay. J Virol Methods 2017 Oct 6. Abstract
submitted by kickingbird at 5 days ago from J Virol Methods 2017 Oct 6
Reduced intensity of the fluorescence signal in the amplification curve was observed when using a WHO recommended real time RT-PCR for influenza virus detection. A single mutation, G189T, in the conserved ... Cho J, Yi H, Jang EY, Lee MS, et al. Mycophenolic mofetil, an alternative antiviral and immunomodulator for the highly pathogenic avian influenza H5N1 virus infection. Biochem Biophys Res Commun 2017 Oct 7. Abstract
submitted by kickingbird at 5 days ago from Biochem Biophys Res Commun 2017 Oct 7
Infection with the highly pathogenic avian influenza H5N1 virus results in a high incidence of mortality in humans. Severe complications from infection are often associated with hypercytokinemia. However, ... Tilmanis D, van Baalen C, Oh DY, Rossignol JF, et. The susceptibility of circulating human influenza viruses to tizoxanide, the active metabolite of nitazoxanide. Antiviral Res 2017 Oct 3. Abstract
submitted by kickingbird at 5 days ago from Antiviral Res 2017 Oct 3
Nitazoxanide is a thiazolide compound that was originally developed as an anti-parasitic agent, but has recently been repurposed for the treatment of influenza virus infections. Thought to exert its anti-influenza ... Carter DM, Darby CA, Johnson SK, Carlock MA, et al. Elicitation of protective antibodies against a broad panel of H1N1 viruses in ferrets pre-immune to historical H1N1 influenza viruses. J Virol 2017 Oct 4. Abstract
submitted by kickingbird at 12 days ago from J Virol 2017 Oct 4
Most pre-clinical animal studies test influenza vaccines in immunologically na?ve animal models, even though the results of vaccination may not accurately reflect the effectiveness of vaccine candidates ... Wong TM, Allen JD, Bebin-Blackwell AG, Carter DM,. COBRA HA elicits hemagglutination-inhibition antibodies against a panel of H3N2 influenza virus co-circulating variants. J Virol 2017 Oct 4. Abstract
submitted by kickingbird at 12 days ago from J Virol 2017 Oct 4
Each influenza season, a set of wild-type viruses, representing one H1N1, one H3N2, 1-2 influenza B isolates, are selected for inclusion in the annual seasonal influenza vaccine. In order to develop broadly ... | |
- 
